CYTK vs DVN · rev $28.6M vs P/E 7.4, rev $7.42B
Cytokinetics Inc (CYTK) versus Devon Energy Corporation (DVN) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Devon Energy Corporation (DVN) is a oil & gas e&p company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported DVN revenue for 2026-06-30 was $7.42B. Net income was $1.91B. Revenue was up 94.8% from 2026-03-31 to 2026-06-30. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
CYTK currently screens at market cap $4.05B. DVN currently screens at market cap $22.42B and trailing P/E 7.4.
Not investment advice. Open the CYTK and DVN stock pages for the full models.
Not investment advice.